Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/1999
04/22/1999WO1999019326A1 Piperidine derivatives
04/22/1999WO1999011624B1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
04/21/1999EP0909759A2 Individual stereoisomers of 7-(3-aminoalkyl)-1-pyrrolidinyl)-quinolones as antibacterial agents
04/21/1999EP0579797B1 Diphosphine ligands
04/21/1999EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
04/21/1999CN1214686A Derivatives of camptothecin for use in treating cancer
04/21/1999CN1214685A Inhibitors of farnesyl protein transferase
04/15/1999WO1999018105A1 Dipyridoimidazolderivatives useful in treating central nervous system disorders
04/15/1999WO1999018104A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
04/15/1999WO1999018081A1 Substituted fused heterocyclic compounds
04/15/1999WO1999018077A1 Fused pyridine derivatives
04/15/1999WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/15/1999WO1999018074A1 Novel lactam metalloprotease inhibitors
04/15/1999WO1999017759A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
04/15/1999WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
04/15/1999DE19744257A1 New tetracyclic pyrido-indole derivatives
04/15/1999CA2305679A1 Novel lactam metalloprotease inhibitors
04/15/1999CA2305348A1 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
04/15/1999CA2305342A1 Novel heterocyclic derivatives useful in treating central nervous system disorders
04/15/1999CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/14/1999EP0907644A1 Pharmaceutical preparation
04/14/1999EP0907640A1 Substituted n-(4-pyridyl)-thioamides with pesticide activity
04/14/1999EP0810991B1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
04/14/1999EP0791035B1 Azamethine dyes
04/14/1999EP0652879B1 1-azaadamantane derivatives as 5-ht4 agonists or antagonists and/or 5-ht3 antagonists
04/14/1999EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS
04/14/1999CN1214045A Process for aminocarbonylation of benzazepines and benzodiazepines
04/14/1999CN1214039A Carbamoyloxy derivatives of mutiline and their use as antibacterials
04/14/1999CN1042937C Substituted fused pyrazolo compounds and their use as herbicides
04/14/1999CN1042936C Substituted aminoquinolone compound, its application and medicinal compsns. containing same
04/13/1999CA2155129C Combinations of retroviral inhibitors
04/13/1999CA2005547C Derivatives of 1,7' (imidazo-(1,2-a)-pyridine)5'-(6'h)ones
04/13/1999CA1340493C Pyridone carboxylic acid derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
04/13/1999CA1340492C Novel naphthyridine-and quinoline-carboxylic acids as bacterial agents
04/08/1999WO1999016755A1 Novel angiogenesis inhibitors
04/08/1999WO1999016753A2 Tricyclic 3-oxo-propanenitrile compounds
04/08/1999WO1999016453A1 Method for the treatment of cystic fibrosis
04/08/1999WO1999016442A2 Sustained release tablet formulation to treat parkinson disease
04/08/1999WO1999016438A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
04/08/1999WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue
04/08/1999WO1998054161A9 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
04/08/1999DE19744027A1 New pyrazolo(3,4-b)pyridine derivatives useful as cGMP agonists
04/08/1999CA2304482A1 Method for the treatment of cystic fibrosis
04/08/1999CA2303830A1 Novel angiogenesis inhibitors
04/08/1999CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds
04/08/1999CA2301869A1 Sustained release tablet formulation to treat parkinson disease
04/07/1999EP0906094A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
04/07/1999EP0805797B1 Process for producing n-arylhydroxylamines and n-hetarylhydroxylamines
04/07/1999CN1213372A Heterocycle-condensed morphinoid derivatives (II)
04/06/1999USRE36187 Herpes simplex virus; human cytomegalovirus
04/06/1999US5892039 Piperazino derivatives as neurokinin antagonists
04/06/1999US5892037 Polymeric adducts of hindered amine-epoxides as stabilizers
04/06/1999US5892033 Metallic chelating dye
04/06/1999US5891891 Use of imidazo 1, 2-A! pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with disfunction of the neural circuits of the basal ganglia
04/06/1999US5891884 Use of an imidazole derivative for preventing and/or treating rhinitis
04/06/1999US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor
04/06/1999US5891872 Inhibit farnesyl-protein transferase
04/06/1999CA1340487C Ph-neutral aqueous solutions of quinolone-carboxylic acids
04/01/1999WO1999015894A2 Method of identification of leads or active compounds
04/01/1999WO1999015535A1 Binuclear complex
04/01/1999WO1999015526A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
04/01/1999WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999WO1999015524A1 Thiazole derivatives
04/01/1999WO1999015500A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999WO1999015169A1 Thrombin inhibitors
04/01/1999CA2304783A1 Method of identification of leads or active compounds
04/01/1999CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999CA2303994A1 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
04/01/1999CA2303096A1 Binuclear complex
04/01/1999CA2302572A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/1999CA2301614A1 Thrombin inhibitors
03/1999
03/31/1999EP0905512A1 Method of identification of leads or active compounds
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/31/1999EP0904271A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
03/31/1999EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
03/31/1999EP0904262A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
03/31/1999EP0904081A1 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
03/31/1999EP0742811B1 Method for preparing pyridine dyes
03/31/1999CN1212695A 4-amino pyrimidine derivates, medicament containing these compounds, their use
03/31/1999CN1212256A Quinolone-and naphthyridone-carboxylic acid derivatives
03/31/1999CN1042731C Ellipticine roserushine derivative as antineoplastic medicine and process for preparing the same
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889035 1-(Arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics
03/30/1999US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists
03/30/1999US5889009 Method of inhibiting cell adhesion
03/30/1999US5889004 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their therapeutic utility
03/30/1999US5888999 Using azacyclic and azabicyclic pyrazine compounds
03/30/1999US5888992 Polar substituted hydrocarbons
03/25/1999WO1999014214A1 Antimicrobial quinolones, their compositions and uses
03/25/1999WO1999014203A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
03/25/1999WO1999014202A2 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
03/25/1999WO1999014199A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
03/25/1999CA2302453A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs
03/25/1999CA2301694A1 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
03/24/1999EP0903144A1 Remedy for retinal neuropathy
03/24/1999EP0902684A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
03/24/1999EP0640085B1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
03/24/1999CN1211985A Fused imidazole derivatives as multidrug resistance modulators
03/24/1999CN1211984A Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
03/24/1999CN1211983A Azabicyclic esters of carbamic acids useful in therapy